These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31776851)

  • 21. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.
    Maree FF; Nsamba P; Mutowembwa P; Rotherham LS; Esterhuysen J; Scott K
    Vaccine; 2015 Jun; 33(25):2909-16. PubMed ID: 25930116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of SAT1 type foot-and-mouth disease virus capsid proteins: influence of receptor usage on the properties of virus particles.
    Maree FF; Blignaut B; Aschenbrenner L; Burrage T; Rieder E
    Virus Res; 2011 Feb; 155(2):462-72. PubMed ID: 21167231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of the VP1/2A junction cleavage by the 3C protease in foot-and-mouth disease virus-infected cells.
    Kristensen T; Normann P; Gullberg M; Fahnøe U; Polacek C; Rasmussen TB; Belsham GJ
    J Gen Virol; 2017 Mar; 98(3):385-395. PubMed ID: 27902359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of vaccines toward the global control and eradication of foot-and-mouth disease.
    Rodriguez LL; Gay CG
    Expert Rev Vaccines; 2011 Mar; 10(3):377-87. PubMed ID: 21434805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development.
    Puckette M; Clark BA; Smith JD; Turecek T; Martel E; Gabbert L; Pisano M; Hurtle W; Pacheco JM; Barrera J; Neilan JG; Rasmussen M
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
    Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation in the VP2 gene of P1-2A capsid protein increases the thermostability of virus-like particles of foot-and-mouth disease virus serotype O.
    Ganji VK; Biswal JK; Lalzampuia H; Basagoudanavar SH; Saravanan P; Tamil Selvan RP; Umapathi V; Reddy GR; Sanyal A; Dechamma HJ
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8883-8893. PubMed ID: 30136205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of two novel sublineages Ind2001BD1 and Ind2001BD2 of foot-and-mouth disease virus serotype O in Bangladesh.
    Siddique MA; Ali MR; Alam ASMRU; Ullah H; Rahman A; Chakrabarty RP; Amin MA; Hoque SA; Nandi SP; Sultana M; Hossain MA
    Transbound Emerg Dis; 2018 Aug; 65(4):1009-1023. PubMed ID: 29457368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in reverse genetics-based vaccines of foot and mouth disease].
    Yang B; Yang F; Wang SH; Zhang Y; Cao WJ; Yin H; Zheng HX
    Bing Du Xue Bao; 2014 Mar; 30(2):213-20. PubMed ID: 24923178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uncleaved 2A-peptide of foot-and-mouth disease virus can display foreign epitope-tag at the virion surface.
    Biswal JK; Subramaniam S; Ranjan R; Pattnaik B
    Infect Genet Evol; 2017 Oct; 54():324-329. PubMed ID: 28734763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    Gullberg M; Lohse L; Bøtner A; McInerney GM; Burman A; Jackson T; Polacek C; Belsham GJ
    PLoS One; 2016; 11(6):e0157435. PubMed ID: 27294397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of foot-and-mouth disease virus serotype A capsid coding (P1) region on a timescale of three decades in an endemic context.
    Das B; Mohapatra JK; Pande V; Subramaniam S; Sanyal A
    Infect Genet Evol; 2016 Jul; 41():36-46. PubMed ID: 27020544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolutionary analysis of serotype A foot-and-mouth disease viruses circulating in Pakistan and Afghanistan during 2002-2009.
    Jamal SM; Ferrari G; Ahmed S; Normann P; Curry S; Belsham GJ
    J Gen Virol; 2011 Dec; 92(Pt 12):2849-2864. PubMed ID: 21813704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of a chimeric foot-and-mouth disease virus DNA vaccine containing structural genes of serotype O in a genome backbone of serotype Asia 1 in guinea pigs.
    Chockalingam AK; Thiyagarajan S; Govindasamy N; Patnaikuni R; Garlapati S; Golla RR; Joyappa DH; Krishnamshetty P; Veluvarti VV
    Acta Virol; 2010; 54(3):189-95. PubMed ID: 20822311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Foot-and-mouth disease virus: Prospects for using knowledge of virus biology to improve control of this continuing global threat.
    Belsham GJ; Kristensen T; Jackson T
    Virus Res; 2020 May; 281():197909. PubMed ID: 32126297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle.
    Barrera J; Brake DA; Kamicker BJ; Purcell C; Kaptur R; Schieber T; Lechtenberg K; Miller TD; Ettyreddy D; Brough DE; Butman BT; Colby M; Neilan JG
    Transbound Emerg Dis; 2018 Apr; 65(2):447-455. PubMed ID: 29076657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Foot and mouth disease virus vaccines.
    Rodriguez LL; Grubman MJ
    Vaccine; 2009 Nov; 27 Suppl 4():D90-4. PubMed ID: 19837296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptive value of foot-and-mouth disease virus capsid substitutions with opposite effects on particle acid stability.
    Caridi F; Cañas-Arranz R; Vázquez-Calvo Á; de León P; Calderón KI; Domingo E; Sobrino F; Martín-Acebes MA
    Sci Rep; 2021 Dec; 11(1):23494. PubMed ID: 34873184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.